100
Participants
Start Date
April 10, 2023
Primary Completion Date
May 31, 2026
Study Completion Date
November 30, 2026
ARINA-1
ARINA-1 (88 mg/mL ascorbic acid, ASC; 150 mg/mL reduced glutathione, GSH)
Standard of care only
Standard 3-therapy immunosuppression regimen and azithromycin
RECRUITING
Columbia University Irving Medical Center, New York
RECRUITING
Johns Hopkins Hospital, Baltimore
RECRUITING
Medical University of South Carolina, Charleston
RECRUITING
Advent Health, Orlando
RECRUITING
University of South Florida, Tampa
RECRUITING
The Ohio State University Wexner Medical Center, Columbus
RECRUITING
Cleveland Clinic, Cleveland
RECRUITING
University of Texas Southwestern Medical Center, Dallas
RECRUITING
University of Iowa Hospital, Iowa City
RECRUITING
University of Minnesota Medical School, Minneapolis
RECRUITING
Washington University School of Medicine, St Louis
RECRUITING
Baylor Scott and White Research Institute, Dallas
RECRUITING
Houston Methodist Hospital, Houston
WITHDRAWN
Dignity Health - St. Joseph's Hospital and Medical Center, Phoenix
RECRUITING
University of California Los Angeles School of Medicine, Los Angeles
RECRUITING
University of California San Diego Health, San Diego
Renovion, Inc.
INDUSTRY